AMPHAmphastar Pharmaceuticals, ...

Nasdaq amphastar.com


$ 42.45 $ -0.20 (-0.47 %)    

Friday, 03-May-2024 15:59:52 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 42.46
$ 43.02
$ 0.00 x 0
$ 0.00 x 0
$ 42.10 - $ 43.02
$ 35.93 - $ 67.66
353,239
na
2.25B
$ 0.72
$ 16.36
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 03-11-2022 12-31-2021 10-K
10 11-08-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 03-15-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-16-2020 12-31-2019 10-K
18 11-08-2019 09-30-2019 10-Q
19 08-09-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 03-15-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-10-2018 03-31-2018 10-Q
25 03-14-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 03-15-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 03-15-2016 12-31-2015 10-K
34 11-13-2015 09-30-2015 10-Q
35 08-13-2015 06-30-2015 10-Q
36 05-14-2015 03-31-2015 10-Q
37 03-26-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
39 08-13-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 federal-trade-commission-targets-junk-patent-listings-for-diabetes-weight-loss-asthma-drugs-from-companies-like-novo-nordisk-astrazeneca

The FTC intensifies efforts against pharmaceutical patent listings, disputing junk patents for diabetes, weight loss, asthma, a...

 amphastar-pharmaceuticals-interested-in-potential-acquisitions-in-endocrinology-focused-companies

Amphastar Pharmaceuticals discusses the future of Baqsimi at the Needham Healthcare Conference, highlighting its potential amid...

 needham-reiterates-hold-on-amphastar-pharma

Needham analyst Serge Belanger reiterates Amphastar Pharma (NASDAQ:AMPH) with a Hold.

 jp-morgan-initiates-coverage-on-amphastar-pharma-with-overweight-rating-announces-price-target-of-60

JP Morgan analyst Ekaterina Knyazkova initiates coverage on Amphastar Pharma (NASDAQ:AMPH) with a Overweight rating and anno...

 amphastar-pharma-q4-eps-088-misses-091-estimate-sales-17810m-beat-17567m-estimate

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.88 per share which missed the analyst consensus estimate of $0...

 earnings-scheduled-for-february-28-2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

 jim-cramer-says-hold-onto-this-biotech-stock-i-dont-understand-why-its-so-inexpensive

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would back Moderna, Inc. (NASDAQ: MRNA) here.

 b-of-a-securities-initiates-coverage-on-amphastar-pharma-with-neutral-rating-announces-price-target-of-63

B of A Securities analyst Jason Gerberry initiates coverage on Amphastar Pharma (NASDAQ:AMPH) with a Neutral rating and anno...

 disney-twilio-transdigm-marathon-digital-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks traded mostly lower, with the Dow Jones falling around 75 points on Thursday. Here are some big stocks recording ga...

 amphastar-pharma-q3-adj-eps-115-beats-069-estimate-sales-18056m-beat-17463m-estimate

Amphastar Pharma (NASDAQ:AMPH) reported quarterly Adj earnings of $1.15 per share which beat the analyst consensus estimate of ...

 earnings-scheduled-for-november-8-2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

 why-cs-disco-are-trading-lower-by-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its...

 amphastar-pharma-q2adj--eps-065-beats-056-estimate-sales-14571m-beat-13737m-estimate

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.5...

 earnings-scheduled-for-august-8-2023

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share o...

 jefferies-reinstates-buy-on-amphastar-pharma-announces-70-price-target

Jefferies analyst Glen Santangelo reinstates Amphastar Pharma (NASDAQ:AMPH) with a Buy and announces $70 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION